Numerous studies suggested that patients with cancer with a high level of LDH may lead to poor prognosis in multiple cancer types due to the antagonism of anti–PD-1/PD-L1 antibodies, and LDH blockade improves the effectiveness of anti–PD-1 therapy (17–19). The gene discussed is PDCD1; the disease is cancer.